valine has been researched along with Arthritis, Rheumatoid in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.33) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 11 (36.67) | 29.6817 |
2010's | 11 (36.67) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Bogunia-Kubik, K; Bugaj, B; Dratwa, M; Iwaszko, M; Jeka, S; Kolossa, K; Korman, L; Świerkot, J; Wiland, P; Wysoczańska, B | 1 |
Roberts, RA | 1 |
Ahmed, S; Chaurasia, S; Dubey, D; Guleria, A; Kumar, D; Kumar, S; Kumari, R; Misra, R; Modi, DR; Singh, R | 1 |
Westhovens, R | 1 |
Bitoun, S; Le Grand, R; Maillere, B; Mariette, X; Roques, P | 1 |
An, Y; Barrish, JC; Briceno, SW; Caceres-Cortes, J; Camac, DM; Caporuscio, C; Carter, PH; Cavallaro, C; Cvijic, ME; Davies, P; Dhar, M; Duncia, JV; Foster, WR; Gardner, DS; Grafstrom, RR; Hynes, J; Khan, JA; Liu, R; Patel, SR; Rose, AV; Santella, JB; Tebben, AJ; Vickery, RD; Watson, AJ; Wu, H; Yang, G; Yarde, M | 1 |
Damjanov, NS; Fleischmann, RM; Hoock, T; Kinnman, N; Kivitz, AJ; Legedza, A | 1 |
Genovese, MC; Kinnman, N; Pacheco-Tena, C; van Vollenhoven, RF; Zhang, Y | 1 |
Gadina, M; O'Shea, JJ; Schwartz, DM | 1 |
Chen, JK; Novoa, R; Tan, CZ | 1 |
Genovese, MC; Kinnman, N; Yang, F; Østergaard, M | 1 |
Iwata, S; Tanaka, Y | 1 |
Prati, C; Streit, G; Toussirot, E; Wendling, D | 1 |
Cetin, E; Kanigür-Sultuybek, G; Onaran, I; Ozdemir, AT; Ozgönenel, L; Tezcan, G | 1 |
French, LE; Hofbauer, GF; Kamarachev, J; Tresch, S; Trueb, RM | 1 |
Ambrose, C; Benjamin, C; Bixler, SA; Cachero, T; Day, E; Gilbride, K; Gong, D; Gorelik, L; Hsu, YM; Kalled, SL; Pelletier, M; Qian, F; Thompson, JS; Whitty, A; Zafari, M | 1 |
KAHN, MF | 1 |
Daneshtalab, N; Jamali, F; Lewanczuk, RZ; Russell, A | 1 |
Bernier, SG; Clark, E; Doyle, B; Hannig, G; Labenski, MT; Lazarus, DD; Thompson, CD; Westlin, WF | 1 |
Brummitt, CF | 1 |
Bernier, SG; Clark, E; Doyle, B; Hannig, G; Hoyt, JG; Karp, RM; Lorusso, J; Westlin, WF | 1 |
Bainbridge, J; Binks, M; Essex, D; Madden, L; Malhotra, R; Paleolog, EM | 1 |
Bernier, SG; Clark, EJ; Doyle, EG; Hannig, G; Hoyt, JG; Karp, RM; Labenski, MT; Lazarus, DD; Lorusso, J; Rogers, AB; Thompson, CD; Wakefield, JD; Westlin, WF | 1 |
Harley, JB; Malone, CC; Williams, RC | 1 |
Hashimoto, H; Maruyama, T; Miyake, S; Miyasaka, N; Okumura, K; Saito, I; Sato, K; Yagita, H | 1 |
Duffy, JM; Grimshaw, J; Guthrie, DJ; McNally, GM; Mollan, RA; Spedding, PL; Trocha-Grimshaw, J; Walker, B; Walsh, E | 1 |
Alam, A; Cantagrel, A; Coppin, H; de Préval, C; Lambert, N; Lulé, J; Mazières, B | 1 |
Bäcklund, J; Gustafsson, T; Holmdahl, R; Kihlberg, J; Wellner, E | 1 |
Baba, S; Kasama, T; Shirasawa, H; Takahashi, T | 1 |
Gao, X; Gazit, E; Livneh, A; Stastny, P | 1 |
3 review(s) available for valine and Arthritis, Rheumatoid
Article | Year |
---|---|
Management of Recurrent Vestibular Neuritis in a Patient Treated for Rheumatoid Arthritis.
Topics: Acyclovir; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Humans; Middle Aged; Prognosis; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Valacyclovir; Valine; Vertigo; Vestibular Function Tests; Vestibular Neuronitis | 2018 |
Clinical efficacy of new JAK inhibitors under development. Just more of the same?
Topics: Adamantane; Arthritis, Rheumatoid; Azetidines; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase 1; Janus Kinase 3; Janus Kinase Inhibitors; Niacinamide; Piperidines; Purines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Sulfonamides; Treatment Outcome; Triazoles; Valine | 2019 |
Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis.
Topics: Administration, Oral; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Azetidines; Clinical Trials as Topic; Heterocyclic Compounds, 2-Ring; Humans; Janus Kinase 1; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyrimidines; Pyrroles; Sulfonamides; Treatment Outcome; Valine | 2016 |
4 trial(s) available for valine and Arthritis, Rheumatoid
Article | Year |
---|---|
A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antirheumatic Agents; Arthritis, Rheumatoid; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Heterocyclic Compounds, 2-Ring; Humans; Janus Kinase 3; Liver; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Surveys and Questionnaires; Treatment Outcome; Valine | 2015 |
VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antirheumatic Agents; Arthritis, Rheumatoid; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Heterocyclic Compounds, 2-Ring; Humans; Janus Kinase 3; Male; Methotrexate; Middle Aged; Treatment Outcome; Valine; Young Adult | 2016 |
Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Heterocyclic Compounds, 2-Ring; Humans; Joints; Magnetic Resonance Imaging; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Valine | 2016 |
Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan.
Topics: Administration, Oral; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Area Under Curve; Arthritis, Rheumatoid; Blood Pressure; Chromatography, High Pressure Liquid; Down-Regulation; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nitrites; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Valine; Valsartan | 2004 |
23 other study(ies) available for valine and Arthritis, Rheumatoid
Article | Year |
---|---|
Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Genetic Predisposition to Disease; Histocompatibility Antigens Class I; Humans; Male; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome; Tumor Necrosis Factor-alpha; Valine | 2020 |
NMR-Based Serum Metabolomics Revealed Distinctive Metabolic Patterns in Reactive Arthritis Compared with Rheumatoid Arthritis.
Topics: Arginine; Arthritis, Reactive; Arthritis, Rheumatoid; HLA-B27 Antigen; Humans; Leucine; Magnetic Resonance Imaging; Metabolomics; Phenylalanine; Prohibitins; Serum; Spondylarthropathies; Valine | 2019 |
Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques.
Topics: Animals; Arthritis, Rheumatoid; Epitopes; Haplotypes; HLA-DRB1 Chains; Lymphocyte Activation; Macaca; Peptides, Cyclic; Phenylalanine; T-Lymphocytes; Valine | 2019 |
Discovery of the CCR1 antagonist, BMS-817399, for the treatment of rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Biological Availability; Clinical Trials, Phase II as Topic; Drug Discovery; Hep G2 Cells; Humans; Male; Microsomes, Liver; Models, Molecular; Piperidines; Pregnane X Receptor; Protein Conformation; Receptors, CCR1; Receptors, Steroid; Species Specificity; Urea; Valine | 2014 |
Decernotinib: A Next-Generation Jakinib.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Heterocyclic Compounds, 2-Ring; Humans; Male; Methotrexate; Valine | 2016 |
Erythematous Plaques on the Buttock.
Topics: Acyclovir; Aged; Anti-Inflammatory Agents; Antiviral Agents; Arthritis, Rheumatoid; Buttocks; Cellulitis; Eosinophilia; Female; Herpes Genitalis; Humans; Prednisone; Pregabalin; Valacyclovir; Valine | 2016 |
Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease.
Topics: Acyclovir; Adalimumab; Adult; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Herpes Zoster; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Retrospective Studies; Risk Factors; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Valacyclovir; Valine | 2008 |
The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients.
Topics: Adult; Aged; Alanine; Amino Acid Substitution; Arthritis, Rheumatoid; DNA Mutational Analysis; Female; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Middle Aged; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polymorphism, Genetic; Turkey; Valine | 2009 |
Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept.
Topics: Acyclovir; Aged; Antiviral Agents; Arthritis, Rheumatoid; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Etanercept; Female; Herpes Zoster; Humans; Immunoglobulin G; Immunosuppressive Agents; Receptors, Tumor Necrosis Factor; Rheumatoid Vasculitis; Risk Factors; Treatment Outcome; Valacyclovir; Valine | 2009 |
Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF.
Topics: Animals; Arthritis, Rheumatoid; Asparagine; B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Cell Maturation Antigen; B-Lymphocytes; Cell Membrane; Cell Separation; Cell Survival; CHO Cells; Cricetinae; Dimerization; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunoglobulin G; Leucine; Lupus Erythematosus, Systemic; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phenotype; Proline; Protein Binding; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Spleen; Tumor Necrosis Factor-alpha; Valine | 2003 |
[Hypotheses on the pathogenesis of malignant rheumatoid polyarthritis. Trial of penicilamine].
Topics: Arthritis; Arthritis, Rheumatoid; Humans; Immunologic Tests; Rheumatoid Factor; Valine | 1962 |
A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis.
Topics: Aminopeptidases; Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cell Division; Cells, Cultured; Cyclohexanes; Down-Regulation; Endothelial Cells; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids, Unsaturated; Humans; Metalloendopeptidases; Proliferating Cell Nuclear Antigen; Rats; Sesquiterpenes; Synovial Membrane; Valine | 2004 |
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine | 2006 |
Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
Topics: Aminopeptidases; Animals; Arthritis, Rheumatoid; Bone Resorption; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Epoxy Compounds; Female; Glycoproteins; Humans; Joints; Osteoclasts; Peptidoglycan; Polysaccharides; Rats; Rats, Inbred Lew; Severity of Illness Index; Valine | 2007 |
Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition.
Topics: Aminopeptidases; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Endothelial Cells; Epoxy Compounds; Fibroblast Growth Factor 2; Glycoproteins; Humans; Male; Methionyl Aminopeptidases; Mice; Mice, Inbred DBA; Neovascularization, Pathologic; Protease Inhibitors; Synovial Membrane; Valine; Vascular Endothelial Growth Factor A | 2007 |
An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis.
Topics: Aminopeptidases; Animals; Arthritis, Rheumatoid; Body Weight; Bone Resorption; Cell Differentiation; Cells, Cultured; Epoxy Compounds; Female; Joints; Metalloendopeptidases; Mice; Osteoclasts; Protease Inhibitors; Rats; Rats, Inbred Lew; Valine | 2008 |
Rheumatoid factors from patients with rheumatoid arthritis react with tryptophan 60 and 95, lysine 58, and arginine 97, on human beta 2-microglobulin.
Topics: Amino Acid Sequence; Antibody Specificity; Arginine; Arthritis, Rheumatoid; Aspartic Acid; beta 2-Microglobulin; Chromatography, Affinity; Computers; Epitopes; Humans; Immunoglobulin A; Immunoglobulin Fc Fragments; Immunoglobulin G; Immunoglobulin M; Isoleucine; Lysine; Molecular Sequence Data; Rheumatoid Factor; Sequence Homology, Amino Acid; Tryptophan; Valine | 1993 |
A possible role of two hydrophobic amino acids in antigen recognition by synovial T cells in rheumatoid arthritis.
Topics: Aged; Amino Acid Sequence; Arthritis, Rheumatoid; Base Sequence; HLA-DR Antigens; Humans; Leucine; Middle Aged; Molecular Sequence Data; Osteoarthritis; Receptors, Antigen, T-Cell, alpha-beta; Synovial Fluid; T-Lymphocytes; Valine | 1993 |
1H-nuclear magnetic resonance studies of human synovial fluid in arthritic disease states as an aid to confirming metabolic activity in the synovial cavity.
Topics: Acetates; Alanine; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Humans; Hyaluronic Acid; Lactates; Lipid Metabolism; Magnetic Resonance Spectroscopy; Osteoarthritis; Synovial Fluid; Valine | 1993 |
Persistence of dominant T cell clones in synovial tissues during rheumatoid arthritis.
Topics: Amino Acid Sequence; Arthritis, Rheumatoid; Clone Cells; Conserved Sequence; Female; Gene Rearrangement, T-Lymphocyte; Humans; Male; Middle Aged; Molecular Sequence Data; Multigene Family; Open Reading Frames; Receptors, Antigen, T-Cell, alpha-beta; Synovial Membrane; T-Lymphocytes; Valine | 1996 |
Synthesis of a C-glycoside analogue of beta-D-galactosyl hydroxynorvaline and its use in immunological studies.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Carbohydrate Conformation; Collagen Type II; Galactose; Glycopeptides; Glycosylation; HLA Antigens; Hybridomas; Immunodominant Epitopes; Interleukin-2; Ligands; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Molecular Structure; Rats; T-Lymphocytes; Valine | 2000 |
Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis.
Topics: Alanine; Amino Acid Sequence; Amyloid; Amyloidosis; Arthritis, Rheumatoid; Female; Humans; Middle Aged; Molecular Sequence Data; Molecular Weight; Serum Amyloid A Protein; Thyroid Gland; Trypsin; Valine | 1992 |
Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility.
Topics: Alanine; Alleles; Amino Acid Sequence; Arthritis, Rheumatoid; Genetic Predisposition to Disease; Glycine; Histocompatibility Antigens Class II; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunoglobulin Variable Region; Israel; Jews; Molecular Sequence Data; Oligonucleotides; Polymerase Chain Reaction; Risk Factors; Valine | 1991 |